Piekos Brian bought KALV
May 21, 2026 · Form 4 insider transaction
Piekos Brian bought 5,000 shares of KalVista Pharmaceuticals Inc, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
N/A
Total value
N/A
InsiderPiekos Brian
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 21, 2026
Filing dateMay 26, 2026
Shares owned after23,150
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.